Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA
PaperCitations, authors & open-access status
Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 57 citations, 2015 year and gold oa status.
57
Citations
2015
Year
gold
OA Status